Located in the Discovery District of Toronto, Avicanna is a diversified and vertically integrated Canadian biopharmaceutical company.
The company’s focus over the past 5 years has been research, development and commercialization of plant-derived cannabinoid-based products for the global consumer, medical, and pharmaceutical market segments.
With an emphasis on research and development, Avicanna is comprised of a team of clinicians, biotech executives and over 10 scientists. Avicanna’s research and medical team determine ratios, doses and delivery forms to provide advanced non-inhalation treatments that are now commercial in Canada. Their research aims to aid various medical conditions such as nausea, osteoarthritis, chronic pain and more.